Faselis C, Doumas M, Kokkinos P, Tsioufis C, Papademetriou V
Veteran Affairs Medical Center, 50 Irving Street NW, 20422, Washington DC, USA.
Curr Vasc Pharmacol. 2014 Jan;12(1):38-46. doi: 10.2174/15701611113119990139.
The sympathetic nervous system is overactivated in resistant hypertension and several other disease conditions. A reciprocal association between the brain and the kidney has been described, in that sympathetic overactivity affects renal function while renal injury stimulates central sympathetic drive. Renal nerve ablation has been recently introduced as a potential alternative for the management of resistant hypertension, mainly due to current limitations in pharmacologic antihypertensive therapy. Data accumulated thus far point towards an efficacious and safe interventional method for the management of treatment resistance, with additional benefits on glucose metabolism and cardiac structure and function. Furthermore, beneficial effects have been observed in patients with chronic kidney disease, obstructive sleep apnea, polycystic ovary syndrome, and sympathetically driven tachyarrhythmias. However, as with every novel technique, several questions need to be answered and concerns need to be addressed before the wide application of this interventional approach.
在顽固性高血压和其他几种疾病状态下,交感神经系统会过度激活。脑与肾之间存在一种相互关联,即交感神经过度活跃会影响肾功能,而肾损伤会刺激中枢交感神经驱动。肾神经消融术最近被引入作为治疗顽固性高血压的一种潜在替代方法,主要是由于目前药物降压治疗存在局限性。迄今为止积累的数据表明,这是一种有效且安全的治疗抵抗性的介入方法,对糖代谢以及心脏结构和功能还有额外益处。此外,在慢性肾病、阻塞性睡眠呼吸暂停、多囊卵巢综合征以及交感神经驱动的快速性心律失常患者中也观察到了有益效果。然而,与每一项新技术一样,在这种介入方法广泛应用之前,有几个问题需要解答,一些担忧也需要解决。